Self-Regulatory Organizations; The Nasdaq Stock Market LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Amend Listing Rules 5605 and 5606, 77903-77906 [2022-27497]
Download as PDF
Federal Register / Vol. 87, No. 243 / Tuesday, December 20, 2022 / Notices
solutions for societal challenges. How
might social, behavioral, and economic
sciences contribute to understanding
possible paths to success and any
hurdles? What public engagement and
participatory models have shown
promise for increasing trust and
understanding of biotechnology?
Data for the Bioeconomy
3. What data types and sources, to
include genomic and multiomic
information, are most critical to drive
advances in health, climate, energy,
food, agriculture, and biomanufacturing,
as well as other bioeconomy-related
R&D? What data gaps currently exist?
4. How can the Federal Government,
in partnership with private, academic,
and non-profit sectors, support a data
ecosystem to drive breakthroughs for the
U.S. bioeconomy? This may include
technologies, software, and policies
needed for data to remain high-quality,
interoperable, accessible, secure, and
understandable across multiple
stakeholder groups.
Building a Vibrant Domestic
Biomanufacturing Ecosystem
5. What is the current state of U.S.
and global biomanufacturing capacity
for health and industrial sectors and
what are the limits of current practice?
6. What can the Federal Government
do to expand and scale domestic
biomanufacturing capacity and
infrastructure? What level of investment
would be meaningful and what
incentive structures could be employed?
7. What are barriers that must be
addressed in order to better enable
domestic supply chains for
biomanufacturing (e.g., feedstocks,
reagents, consumables)?
8. How can the Federal Government
partner with state and local
governments to expand domestic
biomanufacturing capacity, with a
particular focus on underserved
communities?
lotter on DSK11XQN23PROD with NOTICES1
Biobased Products Procurement
9. What are new, environmentally
sustainable biobased products that the
Federal Government could purchase
through its BioPreferred Program? How
can the Federal Government incentivize
development of new categories of
sustainable biobased products?
Biotechnology and Biomanufacturing
Workforce
10. How can the U.S. strengthen and
expand the biotechnology and
biomanufacturing workforce to meet the
needs of industry today and in the
future? What role can government play
at the local, state, and/or Federal level?
VerDate Sep<11>2014
18:41 Dec 19, 2022
Jkt 259001
77903
11. What strategies and program
models have shown promise for
successfully diversifying access to
biomanufacturing and biotechnology
jobs—including those involving
Historically Black Colleges and
Universities, Tribal Colleges and
Universities, and other Minority Serving
Institutions? What factors have stymied
progress in broadening participation in
this workforce?
SECURITIES AND EXCHANGE
COMMISSION
Reducing Risk by Advancing Biosafety
and Biosecurity
Pursuant to section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’),1 and Rule 19b–4 thereunder,2
notice is hereby given that on December
12, 2022, The Nasdaq Stock Market LLC
(‘‘Nasdaq’’ or ‘‘Exchange’’) filed with the
Securities and Exchange Commission
(‘‘Commission’’) the proposed rule
change as described in Items I, II, and
III below, which Items have been
prepared by the Exchange. The
Commission is publishing this notice to
solicit comments on the proposed rule
change from interested persons.
12. What can the Federal Government
do to support applied biosafety research
and biosecurity innovation to reduce
risk while maximizing benefit
throughout the biotechnology and
biomanufacturing lifecycles?
13. How can Federal agencies that
fund, conduct, or sponsor life sciences
research incentivize and enhance
biosafety and biosecurity practices
throughout the United States and
international research enterprises?
Measuring the Bioeconomy
14. What quantitative indicators,
economic or otherwise, are currently
used to measure the contributions of the
U.S. bioeconomy? Are there new
indicators that should be developed?
15. How should the North American
Industry Classification System and the
North American Product Classification
System be revised to enable
characterization of the economic value
of the U.S. bioeconomy? Specifically,
which codes or categories do not
distinguish between functionally
identical bio-based and fossil fuel-based
commodities?
International Engagement
16. What are opportunities for the
U.S. Government to advance research
and development, a skilled workforce,
regulatory cooperation, and data sharing
for the bioeconomy through
international cooperation? Which
partnerships and fora are likely key to
advance these priority areas?
17. What risks are associated with
international biotechnology
development and use, and how can the
U.S. Government work with allies and
partners to mitigate these risks?
Dated: December 15, 2022.
Rachel Wallace,
Deputy General Counsel.
[Release No. 34–96500; File No. SR–
NASDAQ–2022–075]
Self-Regulatory Organizations; The
Nasdaq Stock Market LLC; Notice of
Filing and Immediate Effectiveness of
Proposed Rule Change To Amend
Listing Rules 5605 and 5606
December 14, 2022.
I. Self-Regulatory Organization’s
Statement of the Terms of Substance of
the Proposed Rule Change
The Exchange proposes to simplify
implementation and compliance
tracking of Listing Rules 5605 and 5606,
as described further below.
The text of the proposed rule change
is available on the Exchange’s website at
https://listingcenter.nasdaq.com/
rulebook/nasdaq/rules, at the principal
office of the Exchange, and at the
Commission’s Public Reference Room.
II. Self-Regulatory Organization’s
Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule
Change
In its filing with the Commission, the
Exchange included statements
concerning the purpose of and basis for
the proposed rule change and discussed
any comments it received on the
proposed rule change. The text of these
statements may be examined at the
places specified in Item IV below. The
Exchange has prepared summaries, set
forth in sections A, B, and C below, of
the most significant aspects of such
statements.
A. Self-Regulatory Organization’s
Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule
Change
1. Purpose
On December 1, 2020, the Exchange
filed with the Commission a proposed
rule change to adopt listing rules to
[FR Doc. 2022–27600 Filed 12–19–22; 8:45 am]
1 15
BILLING CODE 3270–F1–P
PO 00000
Frm 00117
Fmt 4703
2 17
Sfmt 4703
E:\FR\FM\20DEN1.SGM
U.S.C. 78s(b)(1).
CFR 240.19b–4.
20DEN1
77904
Federal Register / Vol. 87, No. 243 / Tuesday, December 20, 2022 / Notices
lotter on DSK11XQN23PROD with NOTICES1
advance board diversity and enhance
transparency of diversity statistics
(‘‘Board Diversity Proposal’’).3 On
August 6, 2021 (‘‘Approval Date’’), the
Commission approved the proposal, as
amended (‘‘Board Diversity Rules).4
At the time of filing of the Board
Diversity Proposal, Nasdaq and listed
companies could not know when the
proposal would be approved. Since
directors typically are elected in
connection with the annual shareholder
meeting, Nasdaq wanted to assure that
listed companies had at least one year
from the approval of the rules, or until
their next annual meeting, to take
necessary actions to satisfy the
requirements of the Board Diversity
Rules. Therefore, Nasdaq tied the initial
compliance deadlines in the Board
Diversity Proposal to one year after the
approval date.5 Specifically, on August
8, 2022 (one year after the Approval
Date),6 Nasdaq-listed companies became
subject to the first compliance
condition: disclosing their Board
Diversity Matrix (‘‘Matrix’’).7
Subsequent compliance conditions were
similarly scheduled to take effect
starting two or more years from the
Approval Date.8
Nasdaq has found that this
formulation of the compliance deadlines
is confusing and unnecessarily
complicated. Therefore, Nasdaq now
proposes to make technical changes to
Rule 5605(f)(3) (Alternative Public
Disclosure) and Rule 5605(f)(7)
(Effective Dates/Transition) to simplify
the implementation of the Board
Diversity Rules by eliminating
references to the Approval Date and the
alternative deadline related to the filing
of materials for the company’s annual
meeting, and instead requiring
compliance by December 31st of the
applicable year. Nasdaq is also
proposing to amend Rule 5605(f)(3) to
provide additional flexibility in how a
company can notify Nasdaq about the
alternative public disclosure
permissible under that rule.
3 See Securities Exchange Act Release No. 90574
(December 4, 2020), 85 FR 80472 (SR–NASDAQ–
2020–081).
4 Securities Exchange Act Release No. 92590
(August 6, 2021), 86 FR 44424 (August 12, 2021)
(Approval order). Nasdaq filed an amendment to
the proposal on February 26, 2021. See Amendment
No. 1, available on the Commission’s website at:
https://www.sec.gov/comments/srnasdaq-2020-081/
srnasdaq2020081-8425992-229601.pdf. Pursuant to
Rule 5605(f)(1), ‘‘Approval Date’’ means the date
that the Commission issued an order granting the
approval of this proposed Rule 5605(f).
5 See Rule 5605(f)(1); see also Rule 5605(f)(7) and
5606(e).
6 The Approval Date became August 8, 2022
because August 6, 2022 was a Saturday.
7 See Rule 5606.
8 See Rule 5605(f)(7).
VerDate Sep<11>2014
18:41 Dec 19, 2022
Jkt 259001
Additionally, Nasdaq is proposing a
technical amendment to Rule 5605(f)(3)
to change an erroneous reference to a
non-existent Rule 5606(f)(2)(D).
Effective Dates
Pursuant to Rule 5605(f)(7)(A),
Nasdaq currently requires each
company listed on The Nasdaq Global
Select Market, The Nasdaq Global
Market and The Nasdaq Capital Market
(including a Company with a smaller
board under Rule 5606(f)(2)(D)) to have,
or explain why it does not have, at least
one Diverse 9 director by the later of: (i)
two calendar years after the Approval
Date, which is August 7, 2023 or (ii) the
date the Company files its proxy
statement or its information statement
(or, if the Company does not file a
proxy, in its Form 10–K or 20–F) for the
Company’s annual shareholders meeting
during the calendar year of the First
Effective Date,10 which can be no later
than December 31, 2023. The Exchange
is proposing to replace this deadline
with December 31, 2023, which is the
deadline under the current rule for a
company with a December 31st fiscal
year-end to hold its annual shareholder
meeting during the calendar year of the
First Effective Date.
Similarly, pursuant to Rule
5605(f)(7)(B), Nasdaq currently requires
all companies listed on The Nasdaq
Global Select Market or The Nasdaq
Global Market to have, or explain why
it does not have, at least two Diverse
directors by the later of: (i) four calendar
years after the Approval Date (‘‘Second
NGS/NGM Effective Date’’), which is
August 6, 2025 or (ii) the date the
Company files its proxy statement or its
information statement (or, if the
Company does not file a proxy, in its
Form 10–K or 20–F) for the Company’s
annual shareholders meeting during the
calendar year of the Second NGS/NGM
Effective Date, which can be no later
than December 31, 2025. The Exchange
is proposing to replace this deadline
with December 31, 2025, which is the
deadline under the current rule for a
company with a December 31st fiscal
year-end to hold its annual shareholder
meeting during the calendar year of the
Second NGS/NGM Effective Date.
Lastly, Rule 5605(f)(7)(C) currently
requires each Company listed on The
Nasdaq Capital Market to have, or
9 Pursuant
to Rule 5605(f)(1), ‘‘Diverse’’ means an
individual who self-identifies in one or more of the
following categories: Female, Underrepresented
Minority, or LGBTQ+. ‘‘Female’’ means an
individual who self-identifies her gender as a
woman, without regard to the individual’s
designated sex at birth.
10 The ‘‘First Effective Date’’ is defined as two
calendar years after the Approval Date. See Rule
5605(f)(7)(A).
PO 00000
Frm 00118
Fmt 4703
Sfmt 4703
explain why it does not have, at least
two Diverse directors by the later of: (i)
five calendar years after the Approval
Date (‘‘Second NCM Effective Date’’),
which is August 6, 2026 or (ii) the date
the Company files its proxy statement or
its information statement (or, if the
Company does not file a proxy, in its
Form 10–K or 20–F) for the Company’s
annual shareholders meeting during the
calendar year of the Second NCM
Effective Date, which is no later than
December 31, 2026. The Exchange is
proposing to replace this deadline with
December 31, 2026, which is the
deadline under the current rule for a
company with a December 31st fiscal
year-end to hold its annual shareholder
meeting during the calendar year of the
Second NCM Effective Date.
Nasdaq is also proposing to align the
proposed December 31st deadlines for
Rule 5605(f)(7) with the Rule 5606(f)(3)
deadline for companies to explain why
they do not meet the diversity objectives
of Rule 5606(f)(2). Therefore, Nasdaq is
proposing to amend Rule 5606(f)(3) to
allow for companies to provide such
disclosure on or before December 31st.
Additionally, Rule 5606(e) provides a
deadline for a company’s initial Matrix
disclosure and requires a company to
annually disclose the Matrix thereafter,
but the current rule does not provide a
specific deadline for subsequent
disclosures, other than that such
disclosure must be made in the same
manner as, and concurrently with, the
disclosure required in Rule 5605(f)(3)
for those companies that are subject to
that provision. Therefore, Nasdaq is
proposing to modify Rule 5606(b) to
specify the method of disclosure, which
is the same as outlined in Rule
5605(f)(3), and the December 31st
annual deadline for the required Matrix
disclosure.
Nasdaq believes that using December
31st as the applicable deadline for
various elements of the diversity
objectives of Rule 5605(f) and Matrix
disclosure of Rule 5606 aligns these
deadlines with the end of the fiscal year
for most companies,11 which is also the
deadline for those companies to hold
their annual meeting under Nasdaq’s
rules.12 As such, Nasdaq believes that
aligning the deadline for these
disclosures with the December 31st
11 Approximately 80% of Nasdaq-listed
companies subject to the rule have a December 31st
fiscal year-end.
12 See Rule 5620 (requiring most listed companies
to hold an annual meeting of shareholders no later
than one year after the end of the Company’s fiscal
year-end). Under Rules 5605(f)(3) and 5606(b),
companies can include disclosure about why they
do not meet the applicable diversity objectives of
Rule 5605(f)(2) and the Matrix in the proxy or
information statement for their annual meeting.
E:\FR\FM\20DEN1.SGM
20DEN1
Federal Register / Vol. 87, No. 243 / Tuesday, December 20, 2022 / Notices
deadline for most companies to hold the
annual meeting will simplify both
compliance and compliance monitoring
with these rules.13 In that regard,
Nasdaq notes that while companies tend
to hold their annual meetings at a
similar time each year, they are not
required to do so, and do not necessarily
file their proxies or information
statements at the same time each year.
Moreover, neither Nasdaq nor investors
know ahead of time when a company
will file their proxy statements or
information statements. Establishing a
single deadline for all companies will
therefore simplify Nasdaq’s ability to
review for instances of non-compliance
and give investors a final date to expect
a company’s disclosure.
Notice to Nasdaq
Currently, if a Nasdaq-listed company
posts its Matrix disclosure or its
explanation for why the company does
not satisfy the diverse director objective
on its website, then the company must
also submit a URL link to the disclosure
through the Nasdaq Listing Center
within one business day after posting on
the company’s website.14 To provide
additional flexibility to companies,
Nasdaq is proposing to also allow
companies to submit the URL link via
email to ‘‘drivingdiversity@
nasdaq.com’’. Nasdaq notes that
providing the additional alternative may
simplify compliance for companies and
will not affect Nasdaq’s ability to review
for instances of non-compliance.
lotter on DSK11XQN23PROD with NOTICES1
Technical Changes
Nasdaq is proposing a technical
amendment to Rule 5605(f)(3) to change
an erroneous reference to a non-existent
Rule 5606(f)(2)(D). The reference was
intended to be 5605(f)(2)(D). Nasdaq is
also proposing to remove Rule 5606(e)
since the rule became effective and
operative over a year ago and Nasdaq
believes the provision is no longer
relevant.
2. Statutory Basis
The Exchange believes that its
proposal is consistent with section 6(b)
of the Act,15 in general, and furthers the
objectives of section 6(b)(1) of the Act,16
in particular, in that the Exchange is
organized and has the capacity to be
able to carry out the purposes of the Act
and to comply and enforce compliance
by its members and persons associated
with its member. The Exchange believe
13 Of course, companies will continue to be able
to comply earlier than the proposed December 31st
deadline.
14 See Rule 5605(f)(3).
15 15 U.S.C. 78f(b).
16 15 U.S.C. 78f(b)(1).
VerDate Sep<11>2014
18:41 Dec 19, 2022
Jkt 259001
the proposal is also consistent with
section 6(b)(5) of the Act,17 in
particular, in that it is designed to
promote just and equitable principles of
trade, to remove impediments to and
perfect the mechanism of a free and
open market and a national market
system, and, in general to protect
investors and the public interest.
It is consistent with the Act to amend
Rule 5605(f)(7) governing the effective
dates of the Diverse director objective.
When proposing changes to its
rulebook, Nasdaq must ensure that the
changes remain consistent with other
provisions. Presently, companies that
opt to publish the alternative public
disclosure rather than satisfy the
Diverse director objective must do so in
the same manner, and concurrently with
Rule 5606—the Matrix disclosure.18 The
proposed amendments to Rule
5605(f)(7) aligns the annual deadline for
companies that opt to explain why they
do not satisfy the Diverse director
objective with the proposed annual
deadline for the Matrix. Companies will
continue to have the option of
publishing the disclosure sooner than
the proposed December 31st deadline.
Similarly, the Exchange’s proposal to
amend its rule requiring Nasdaq-listed
companies to publicly disclose board
diversity statistics using the Matrix, or
a substantially similar format, at Rule
5606(e), is consistent with the Act.
Clarifying the date for subsequent
Matrix disclosures ensures that all
Nasdaq-listed companies will disclose a
Matrix during each calendar year.
Additionally, proposing December 31st
as the deadline each year simplifies
compliance and more closely aligns the
deadline with the end of the fiscal year
for most companies, which is also their
deadline to hold an annual meeting.
Moreover, this revised formulation
provides all Nasdaq-listed companies
with the same compliance deadline,
which is the same as the latest calendar
date for compliance under the current
rule.19 As discussed above, Companies
will continue to have the option of
publishing the disclosure sooner than
the proposed December 31st deadline.
Nasdaq also believes that having the
same annual deadline date for all
companies will simplify Nasdaq’s
ability to track non-compliant
17 15
U.S.C. 78f(b)(5).
Rule 5605(f)(3) and Rule 5606(b).
19 Currently, all Nasdaq-listed companies are
required to file an annual proxy or information
statement by the end of the company’s fiscal year.
The end of the fiscal year for most Nasdaq-listed
companies is December 31st. Therefore, Nasdaq is
proposing to simplify the deadlines by aligning the
Board Diversity Rule deadlines with the most
company’s fiscal year end.
18 See
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
77905
companies and give investors a final
date to expect a company’s disclosure.
Additionally, it is consistent with the
Act to amend Rule 5605(f)(3) to give
companies an additional alternative for
submitting the URL link to their
disclosures. The additional option of
submitting the URL via email simplifies
compliance and gives companies
flexibility in meeting their
requirements. Moreover, there will be
no impact on Nasdaq’s ability to review
for instances of non-compliance.
B. Self-Regulatory Organization’s
Statement on Burden on Competition
The Exchange does not believe that
the proposed rule change will impose
any burden on competition not
necessary or appropriate in furtherance
of the purposes of the Act. All
companies would continue to be
required to make the same disclosure of
their board-level statistical information
and will have the same deadline for that
disclosure. Additionally, all companies
would be given the same flexibility of
alternatively submitting the URL link to
their disclosure via email. Similarly, all
companies would be given the same
maximum amount of time to publish
their Matrix and to satisfy the Diverse
director objective.
Moreover, none of the proposed
changes will unduly burden intramarket competition among various
Exchange participants. Participants will
experience no competitive impact from
the proposals, as these proposals are
merely intended to assist companies in
maintaining compliance with the Board
Diversity Rules by providing additional
flexibility, clarifying certain provisions,
and maintaining consistency among the
provisions.
C. Self-Regulatory Organization’s
Statement on Comments on the
Proposed Rule Change Received From
Members, Participants, or Others
No written comments were either
solicited or received.
III. Date of Effectiveness of the
Proposed Rule Change and Timing for
Commission Action
Because the foregoing proposed rule
change does not: (i) significantly affect
the protection of investors or the public
interest; (ii) impose any significant
burden on competition; and (iii) become
operative for 30 days from the date on
which it was filed, or such shorter time
as the Commission may designate, it has
become effective pursuant to section
19(b)(3)(A)(iii) of the Act 20 and
20 15
E:\FR\FM\20DEN1.SGM
U.S.C. 78s(b)(3)(A)(iii).
20DEN1
77906
Federal Register / Vol. 87, No. 243 / Tuesday, December 20, 2022 / Notices
subparagraph (f)(6) of Rule 19b–4
thereunder.21
At any time within 60 days of the
filing of the proposed rule change, the
Commission summarily may
temporarily suspend such rule change if
it appears to the Commission that such
action is: (i) necessary or appropriate in
the public interest; (ii) for the protection
of investors; or (iii) otherwise in
furtherance of the purposes of the Act.
If the Commission takes such action, the
Commission shall institute proceedings
to determine whether the proposed rule
should be approved or disapproved.
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views, and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.22
Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2022–27497 Filed 12–19–22; 8:45 am]
Electronic Comments
BILLING CODE 8011–01–P
• Use the Commission’s internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an email to rule-comments@
sec.gov. Please include File Number SR–
NASDAQ–2022–075.
SECURITIES AND EXCHANGE
COMMISSION
Paper Comments
• Send paper comments in triplicate
to Secretary, Securities and Exchange
Commission, 100 F Street NE,
Washington, DC 20549–1090.
All submissions should refer to File
Number SR–NASDAQ–2022–075. This
file number should be included on the
subject line if email is used. To help the
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
post all comments on the Commission’s
internet website (https://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for website viewing and
printing in the Commission’s Public
lotter on DSK11XQN23PROD with NOTICES1
Reference Room, 100 F Street NE,
Washington, DC 20549, on official
business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the
filing also will be available for
inspection and copying at the principal
office of the Exchange. All comments
received will be posted without change.
Persons submitting comments are
cautioned that we do not redact or edit
personal identifying information from
comment submissions. You should
submit only information that you wish
to make available publicly. All
submissions should refer to File
Number SR–NASDAQ–2022–075, and
should be submitted on or before
January 10, 2023.
21 17 CFR 240.19b–4(f)(6). In addition, Rule 19b–
4(f)(6) requires a self-regulatory organization to give
the Commission written notice of its intent to file
the proposed rule change at least five business days
prior to the date of filing of the proposed rule
change, or such shorter time as designated by the
Commission. The Exchange has satisfied this
requirement.
VerDate Sep<11>2014
18:41 Dec 19, 2022
Jkt 259001
[SEC File No. 270–312, OMB Control No.
3235–0354]
Proposed Collection; Comment
Request; Extension: Rule 19b–1
Upon Written Request, Copies Available
From: Securities and Exchange
Commission, Office of FOIA Services,
100 F Street NE, Washington, DC
20549–2736
Notice is hereby given that, pursuant
to the Paperwork Reduction Act of 1995
(44 U.S.C. 350l–3520), the Securities
and Exchange Commission
(‘‘Commission’’) is soliciting comments
on the collection of information
summarized below. The Commission
plans to submit this existing collection
of information to the Office of
Management and Budget for extension
and approval.
Section 19(b) of the Investment
Company Act of 1940 (the ‘‘Act’’) (15
U.S.C. 80a–19(b)) authorizes the
Commission to regulate registered
investment company (‘‘fund’’)
distributions of long-term capital gains
made more frequently than once every
twelve months. Accordingly, rule 19b–
1 under the Act (17 CFR 270.19b–1)
regulates the frequency of fund
distributions of capital gains. Rule 19b–
1(c) states that the rule does not apply
to a unit investment trust (‘‘UIT’’) if it
is engaged exclusively in the business of
investing in certain eligible securities
22 17
PO 00000
CFR 200.30–3(a)(12).
Frm 00120
Fmt 4703
Sfmt 4703
(generally, fixed-income securities),
provided that: (i) the capital gains
distribution falls within one of five
categories specified in the rule 1 and (ii)
the distribution is accompanied by a
report to the unitholder that clearly
describes the distribution as a capital
gains distribution (the ‘‘notice
requirement’’).2 Rule 19b–1(e) permits a
fund to apply to the Commission for
permission to distribute long-term
capital gains that would otherwise be
prohibited by the rule if the fund did
not foresee the circumstances that
created the need for the distribution.
The application must set forth the
pertinent facts and explain the
circumstances that justify the
distribution.3 An application that meets
those requirements is deemed to be
granted unless the Commission denies
the request within 15 days after the
Commission receives the application.
Commission staff estimates that one
fund will file an application under rule
19b–1(e) each year.4 The staff
understands that if a fund files an
application it generally uses outside
counsel to prepare the application. The
cost burden of using outside counsel is
discussed in Item 13 below. The staff
estimates that, on average, a fund’s
investment adviser would spend
approximately 4 hours to review an
application, including 3.5 hours by an
assistant general counsel at a cost of
$510 per hour and 0.5 hours by an
administrative assistant at a cost of $89
per hour, and the fund’s board of
directors would spend an additional 1
hour at a cost of $4,770 per hour, for a
total of 5 hours.5 Thus, the staff
1 17
CFR 270.19b–1(c)(1).
notice requirement in rule 19b–1(c)(2)
supplements the notice requirement of section 19(a)
[15 U.S.C. 80a–19(a)], which requires any
distribution in the nature of a dividend payment to
be accompanied by a notice disclosing the source
of the distribution.
3 Rule 19b–1(e) also requires that the application
comply with rule 0–2 [17 CFR 270.02] under the
Act, which sets forth the general requirements for
papers and applications filed with the Commission
pursuant to the Act and rules thereunder.
4 This estimate is based on the average number of
applications filed with the Commission pursuant to
rule 19b–1(e) in the prior three-year period.
5 The estimate for assistant general counsels is
from SIFMA’s Management & Professional Earnings
in the Securities Industry 2013, modified by
Commission staff to account for an 1800-hour workyear and inflation and multiplied by 5.35 to account
for bonuses, firm size, employee benefits and
overhead. The estimate for administrative assistants
is from SIFMA’s Office Salaries in the Securities
Industry 2013, modified by Commission staff to
account for an 1800-hour work-year and inflation
and multiplied by 2.93 to account for bonuses, firm
size, employee benefits and overhead. The staff
previously estimated in 2009 that the average cost
of board of director time was $4,000 per hour for
the board as a whole, based on information received
from funds and their counsel. Adjusting for
2 The
E:\FR\FM\20DEN1.SGM
20DEN1
Agencies
[Federal Register Volume 87, Number 243 (Tuesday, December 20, 2022)]
[Notices]
[Pages 77903-77906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27497]
=======================================================================
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[Release No. 34-96500; File No. SR-NASDAQ-2022-075]
Self-Regulatory Organizations; The Nasdaq Stock Market LLC;
Notice of Filing and Immediate Effectiveness of Proposed Rule Change To
Amend Listing Rules 5605 and 5606
December 14, 2022.
Pursuant to section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on December 12, 2022, The Nasdaq Stock Market LLC (``Nasdaq'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I, II,
and III below, which Items have been prepared by the Exchange. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------
\1\ 15 U.S.C. 78s(b)(1).
\2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------
I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change
The Exchange proposes to simplify implementation and compliance
tracking of Listing Rules 5605 and 5606, as described further below.
The text of the proposed rule change is available on the Exchange's
website at https://listingcenter.nasdaq.com/rulebook/nasdaq/rules, at
the principal office of the Exchange, and at the Commission's Public
Reference Room.
II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change
In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant aspects of such
statements.
A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change
1. Purpose
On December 1, 2020, the Exchange filed with the Commission a
proposed rule change to adopt listing rules to
[[Page 77904]]
advance board diversity and enhance transparency of diversity
statistics (``Board Diversity Proposal'').\3\ On August 6, 2021
(``Approval Date''), the Commission approved the proposal, as amended
(``Board Diversity Rules).\4\
---------------------------------------------------------------------------
\3\ See Securities Exchange Act Release No. 90574 (December 4,
2020), 85 FR 80472 (SR-NASDAQ-2020-081).
\4\ Securities Exchange Act Release No. 92590 (August 6, 2021),
86 FR 44424 (August 12, 2021) (Approval order). Nasdaq filed an
amendment to the proposal on February 26, 2021. See Amendment No. 1,
available on the Commission's website at: https://www.sec.gov/comments/srnasdaq-2020-081/srnasdaq2020081-8425992-229601.pdf.
Pursuant to Rule 5605(f)(1), ``Approval Date'' means the date that
the Commission issued an order granting the approval of this
proposed Rule 5605(f).
---------------------------------------------------------------------------
At the time of filing of the Board Diversity Proposal, Nasdaq and
listed companies could not know when the proposal would be approved.
Since directors typically are elected in connection with the annual
shareholder meeting, Nasdaq wanted to assure that listed companies had
at least one year from the approval of the rules, or until their next
annual meeting, to take necessary actions to satisfy the requirements
of the Board Diversity Rules. Therefore, Nasdaq tied the initial
compliance deadlines in the Board Diversity Proposal to one year after
the approval date.\5\ Specifically, on August 8, 2022 (one year after
the Approval Date),\6\ Nasdaq-listed companies became subject to the
first compliance condition: disclosing their Board Diversity Matrix
(``Matrix'').\7\ Subsequent compliance conditions were similarly
scheduled to take effect starting two or more years from the Approval
Date.\8\
---------------------------------------------------------------------------
\5\ See Rule 5605(f)(1); see also Rule 5605(f)(7) and 5606(e).
\6\ The Approval Date became August 8, 2022 because August 6,
2022 was a Saturday.
\7\ See Rule 5606.
\8\ See Rule 5605(f)(7).
---------------------------------------------------------------------------
Nasdaq has found that this formulation of the compliance deadlines
is confusing and unnecessarily complicated. Therefore, Nasdaq now
proposes to make technical changes to Rule 5605(f)(3) (Alternative
Public Disclosure) and Rule 5605(f)(7) (Effective Dates/Transition) to
simplify the implementation of the Board Diversity Rules by eliminating
references to the Approval Date and the alternative deadline related to
the filing of materials for the company's annual meeting, and instead
requiring compliance by December 31st of the applicable year. Nasdaq is
also proposing to amend Rule 5605(f)(3) to provide additional
flexibility in how a company can notify Nasdaq about the alternative
public disclosure permissible under that rule. Additionally, Nasdaq is
proposing a technical amendment to Rule 5605(f)(3) to change an
erroneous reference to a non-existent Rule 5606(f)(2)(D).
Effective Dates
Pursuant to Rule 5605(f)(7)(A), Nasdaq currently requires each
company listed on The Nasdaq Global Select Market, The Nasdaq Global
Market and The Nasdaq Capital Market (including a Company with a
smaller board under Rule 5606(f)(2)(D)) to have, or explain why it does
not have, at least one Diverse \9\ director by the later of: (i) two
calendar years after the Approval Date, which is August 7, 2023 or (ii)
the date the Company files its proxy statement or its information
statement (or, if the Company does not file a proxy, in its Form 10-K
or 20-F) for the Company's annual shareholders meeting during the
calendar year of the First Effective Date,\10\ which can be no later
than December 31, 2023. The Exchange is proposing to replace this
deadline with December 31, 2023, which is the deadline under the
current rule for a company with a December 31st fiscal year-end to hold
its annual shareholder meeting during the calendar year of the First
Effective Date.
---------------------------------------------------------------------------
\9\ Pursuant to Rule 5605(f)(1), ``Diverse'' means an individual
who self-identifies in one or more of the following categories:
Female, Underrepresented Minority, or LGBTQ+. ``Female'' means an
individual who self-identifies her gender as a woman, without regard
to the individual's designated sex at birth.
\10\ The ``First Effective Date'' is defined as two calendar
years after the Approval Date. See Rule 5605(f)(7)(A).
---------------------------------------------------------------------------
Similarly, pursuant to Rule 5605(f)(7)(B), Nasdaq currently
requires all companies listed on The Nasdaq Global Select Market or The
Nasdaq Global Market to have, or explain why it does not have, at least
two Diverse directors by the later of: (i) four calendar years after
the Approval Date (``Second NGS/NGM Effective Date''), which is August
6, 2025 or (ii) the date the Company files its proxy statement or its
information statement (or, if the Company does not file a proxy, in its
Form 10-K or 20-F) for the Company's annual shareholders meeting during
the calendar year of the Second NGS/NGM Effective Date, which can be no
later than December 31, 2025. The Exchange is proposing to replace this
deadline with December 31, 2025, which is the deadline under the
current rule for a company with a December 31st fiscal year-end to hold
its annual shareholder meeting during the calendar year of the Second
NGS/NGM Effective Date.
Lastly, Rule 5605(f)(7)(C) currently requires each Company listed
on The Nasdaq Capital Market to have, or explain why it does not have,
at least two Diverse directors by the later of: (i) five calendar years
after the Approval Date (``Second NCM Effective Date''), which is
August 6, 2026 or (ii) the date the Company files its proxy statement
or its information statement (or, if the Company does not file a proxy,
in its Form 10-K or 20-F) for the Company's annual shareholders meeting
during the calendar year of the Second NCM Effective Date, which is no
later than December 31, 2026. The Exchange is proposing to replace this
deadline with December 31, 2026, which is the deadline under the
current rule for a company with a December 31st fiscal year-end to hold
its annual shareholder meeting during the calendar year of the Second
NCM Effective Date.
Nasdaq is also proposing to align the proposed December 31st
deadlines for Rule 5605(f)(7) with the Rule 5606(f)(3) deadline for
companies to explain why they do not meet the diversity objectives of
Rule 5606(f)(2). Therefore, Nasdaq is proposing to amend Rule
5606(f)(3) to allow for companies to provide such disclosure on or
before December 31st.
Additionally, Rule 5606(e) provides a deadline for a company's
initial Matrix disclosure and requires a company to annually disclose
the Matrix thereafter, but the current rule does not provide a specific
deadline for subsequent disclosures, other than that such disclosure
must be made in the same manner as, and concurrently with, the
disclosure required in Rule 5605(f)(3) for those companies that are
subject to that provision. Therefore, Nasdaq is proposing to modify
Rule 5606(b) to specify the method of disclosure, which is the same as
outlined in Rule 5605(f)(3), and the December 31st annual deadline for
the required Matrix disclosure.
Nasdaq believes that using December 31st as the applicable deadline
for various elements of the diversity objectives of Rule 5605(f) and
Matrix disclosure of Rule 5606 aligns these deadlines with the end of
the fiscal year for most companies,\11\ which is also the deadline for
those companies to hold their annual meeting under Nasdaq's rules.\12\
As such, Nasdaq believes that aligning the deadline for these
disclosures with the December 31st
[[Page 77905]]
deadline for most companies to hold the annual meeting will simplify
both compliance and compliance monitoring with these rules.\13\ In that
regard, Nasdaq notes that while companies tend to hold their annual
meetings at a similar time each year, they are not required to do so,
and do not necessarily file their proxies or information statements at
the same time each year. Moreover, neither Nasdaq nor investors know
ahead of time when a company will file their proxy statements or
information statements. Establishing a single deadline for all
companies will therefore simplify Nasdaq's ability to review for
instances of non-compliance and give investors a final date to expect a
company's disclosure.
---------------------------------------------------------------------------
\11\ Approximately 80% of Nasdaq-listed companies subject to the
rule have a December 31st fiscal year-end.
\12\ See Rule 5620 (requiring most listed companies to hold an
annual meeting of shareholders no later than one year after the end
of the Company's fiscal year-end). Under Rules 5605(f)(3) and
5606(b), companies can include disclosure about why they do not meet
the applicable diversity objectives of Rule 5605(f)(2) and the
Matrix in the proxy or information statement for their annual
meeting.
\13\ Of course, companies will continue to be able to comply
earlier than the proposed December 31st deadline.
---------------------------------------------------------------------------
Notice to Nasdaq
Currently, if a Nasdaq-listed company posts its Matrix disclosure
or its explanation for why the company does not satisfy the diverse
director objective on its website, then the company must also submit a
URL link to the disclosure through the Nasdaq Listing Center within one
business day after posting on the company's website.\14\ To provide
additional flexibility to companies, Nasdaq is proposing to also allow
companies to submit the URL link via email to
``[email protected]''. Nasdaq notes that providing the
additional alternative may simplify compliance for companies and will
not affect Nasdaq's ability to review for instances of non-compliance.
---------------------------------------------------------------------------
\14\ See Rule 5605(f)(3).
---------------------------------------------------------------------------
Technical Changes
Nasdaq is proposing a technical amendment to Rule 5605(f)(3) to
change an erroneous reference to a non-existent Rule 5606(f)(2)(D). The
reference was intended to be 5605(f)(2)(D). Nasdaq is also proposing to
remove Rule 5606(e) since the rule became effective and operative over
a year ago and Nasdaq believes the provision is no longer relevant.
2. Statutory Basis
The Exchange believes that its proposal is consistent with section
6(b) of the Act,\15\ in general, and furthers the objectives of section
6(b)(1) of the Act,\16\ in particular, in that the Exchange is
organized and has the capacity to be able to carry out the purposes of
the Act and to comply and enforce compliance by its members and persons
associated with its member. The Exchange believe the proposal is also
consistent with section 6(b)(5) of the Act,\17\ in particular, in that
it is designed to promote just and equitable principles of trade, to
remove impediments to and perfect the mechanism of a free and open
market and a national market system, and, in general to protect
investors and the public interest.
---------------------------------------------------------------------------
\15\ 15 U.S.C. 78f(b).
\16\ 15 U.S.C. 78f(b)(1).
\17\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------
It is consistent with the Act to amend Rule 5605(f)(7) governing
the effective dates of the Diverse director objective. When proposing
changes to its rulebook, Nasdaq must ensure that the changes remain
consistent with other provisions. Presently, companies that opt to
publish the alternative public disclosure rather than satisfy the
Diverse director objective must do so in the same manner, and
concurrently with Rule 5606--the Matrix disclosure.\18\ The proposed
amendments to Rule 5605(f)(7) aligns the annual deadline for companies
that opt to explain why they do not satisfy the Diverse director
objective with the proposed annual deadline for the Matrix. Companies
will continue to have the option of publishing the disclosure sooner
than the proposed December 31st deadline.
---------------------------------------------------------------------------
\18\ See Rule 5605(f)(3) and Rule 5606(b).
---------------------------------------------------------------------------
Similarly, the Exchange's proposal to amend its rule requiring
Nasdaq-listed companies to publicly disclose board diversity statistics
using the Matrix, or a substantially similar format, at Rule 5606(e),
is consistent with the Act. Clarifying the date for subsequent Matrix
disclosures ensures that all Nasdaq-listed companies will disclose a
Matrix during each calendar year. Additionally, proposing December 31st
as the deadline each year simplifies compliance and more closely aligns
the deadline with the end of the fiscal year for most companies, which
is also their deadline to hold an annual meeting. Moreover, this
revised formulation provides all Nasdaq-listed companies with the same
compliance deadline, which is the same as the latest calendar date for
compliance under the current rule.\19\ As discussed above, Companies
will continue to have the option of publishing the disclosure sooner
than the proposed December 31st deadline. Nasdaq also believes that
having the same annual deadline date for all companies will simplify
Nasdaq's ability to track non-compliant companies and give investors a
final date to expect a company's disclosure.
---------------------------------------------------------------------------
\19\ Currently, all Nasdaq-listed companies are required to file
an annual proxy or information statement by the end of the company's
fiscal year. The end of the fiscal year for most Nasdaq-listed
companies is December 31st. Therefore, Nasdaq is proposing to
simplify the deadlines by aligning the Board Diversity Rule
deadlines with the most company's fiscal year end.
---------------------------------------------------------------------------
Additionally, it is consistent with the Act to amend Rule
5605(f)(3) to give companies an additional alternative for submitting
the URL link to their disclosures. The additional option of submitting
the URL via email simplifies compliance and gives companies flexibility
in meeting their requirements. Moreover, there will be no impact on
Nasdaq's ability to review for instances of non-compliance.
B. Self-Regulatory Organization's Statement on Burden on Competition
The Exchange does not believe that the proposed rule change will
impose any burden on competition not necessary or appropriate in
furtherance of the purposes of the Act. All companies would continue to
be required to make the same disclosure of their board-level
statistical information and will have the same deadline for that
disclosure. Additionally, all companies would be given the same
flexibility of alternatively submitting the URL link to their
disclosure via email. Similarly, all companies would be given the same
maximum amount of time to publish their Matrix and to satisfy the
Diverse director objective.
Moreover, none of the proposed changes will unduly burden intra-
market competition among various Exchange participants. Participants
will experience no competitive impact from the proposals, as these
proposals are merely intended to assist companies in maintaining
compliance with the Board Diversity Rules by providing additional
flexibility, clarifying certain provisions, and maintaining consistency
among the provisions.
C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others
No written comments were either solicited or received.
III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action
Because the foregoing proposed rule change does not: (i)
significantly affect the protection of investors or the public
interest; (ii) impose any significant burden on competition; and (iii)
become operative for 30 days from the date on which it was filed, or
such shorter time as the Commission may designate, it has become
effective pursuant to section 19(b)(3)(A)(iii) of the Act \20\ and
[[Page 77906]]
subparagraph (f)(6) of Rule 19b-4 thereunder.\21\
---------------------------------------------------------------------------
\20\ 15 U.S.C. 78s(b)(3)(A)(iii).
\21\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)
requires a self-regulatory organization to give the Commission
written notice of its intent to file the proposed rule change at
least five business days prior to the date of filing of the proposed
rule change, or such shorter time as designated by the Commission.
The Exchange has satisfied this requirement.
---------------------------------------------------------------------------
At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is: (i)
necessary or appropriate in the public interest; (ii) for the
protection of investors; or (iii) otherwise in furtherance of the
purposes of the Act. If the Commission takes such action, the
Commission shall institute proceedings to determine whether the
proposed rule should be approved or disapproved.
IV. Solicitation of Comments
Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:
Electronic Comments
Use the Commission's internet comment form (https://www.sec.gov/rules/sro.shtml); or
Send an email to [email protected]. Please include
File Number SR-NASDAQ-2022-075.
Paper Comments
Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE, Washington, DC 20549-1090.
All submissions should refer to File Number SR-NASDAQ-2022-075. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's internet website (https://www.sec.gov/rules/sro.shtml).
Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for website viewing and printing in
the Commission's Public Reference Room, 100 F Street NE, Washington, DC
20549, on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of the filing also will be available for inspection
and copying at the principal office of the Exchange. All comments
received will be posted without change. Persons submitting comments are
cautioned that we do not redact or edit personal identifying
information from comment submissions. You should submit only
information that you wish to make available publicly. All submissions
should refer to File Number SR-NASDAQ-2022-075, and should be submitted
on or before January 10, 2023.
For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\22\
---------------------------------------------------------------------------
\22\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------
Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2022-27497 Filed 12-19-22; 8:45 am]
BILLING CODE 8011-01-P